AKR1C4 Gene 46,XY Sex Reversal Type 8 Modifier NGS Genetic DNA Test
Comprehensive Genetic Analysis for Reproductive Health
The AKR1C4 Gene 46,XY Sex Reversal Type 8 Modifier NGS Genetic DNA Test represents a breakthrough in reproductive genetic diagnostics. This advanced testing method provides crucial insights into disorders of sexual development, specifically focusing on the AKR1C4 gene’s role in 46,XY sex reversal conditions. Understanding these genetic factors is essential for accurate diagnosis, appropriate treatment planning, and comprehensive patient care.
What Does This Test Measure and Detect?
This sophisticated genetic test specifically targets mutations and variations in the AKR1C4 gene using Next-Generation Sequencing technology. The test detects:
- Pathogenic variants in the AKR1C4 gene associated with 46,XY sex reversal
- Genetic modifications affecting steroid hormone metabolism
- Mutations that disrupt normal male sexual development
- Genetic markers indicating potential reproductive disorders
- Variations affecting androgen biosynthesis pathways
Who Should Consider This Genetic Test?
This test is particularly recommended for individuals presenting with:
- Ambiguous genitalia at birth
- Delayed or abnormal puberty development
- Infertility concerns with unknown causes
- Family history of sexual development disorders
- 46,XY individuals with female external genitalia
- Unexplained reproductive health issues
- Suspected disorders of sex development (DSD)
Key Benefits of AKR1C4 Genetic Testing
Undergoing this comprehensive genetic analysis provides numerous advantages:
- Accurate Diagnosis: Precise identification of genetic causes for reproductive disorders
- Personalized Treatment: Tailored medical interventions based on genetic findings
- Family Planning Guidance: Informed reproductive decisions and genetic counseling
- Early Intervention: Timely management of associated health conditions
- Comprehensive Understanding: Clear explanation of underlying biological mechanisms
- Peace of Mind: Resolution of diagnostic uncertainty
Understanding Your Test Results
Our genetic specialists provide comprehensive interpretation of your AKR1C4 test results:
- Positive Result: Indicates the presence of AKR1C4 gene mutations associated with 46,XY sex reversal
- Negative Result: Suggests no detectable mutations in the analyzed gene regions
- Variant of Uncertain Significance: Requires additional clinical correlation and family studies
- Carrier Status: Information about genetic risk for future generations
All results are accompanied by detailed explanations and recommendations from our certified genetic counselors.
Test Pricing Information
| Test Feature | Details |
|---|---|
| Test Name | AKR1C4 Gene 46,XY Sex Reversal Type 8 Modifier NGS Genetic DNA Test |
| Discount Price | $500 USD |
| Regular Price | $700 USD |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type | Blood |
Nationwide Testing Availability
We proudly serve patients across the United States with convenient testing locations in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art laboratories ensure consistent, reliable results regardless of your location.
Pre-Test Requirements and Preparation
To ensure optimal testing outcomes, we recommend:
- Comprehensive clinical history documentation
- Genetic counseling session prior to testing
- Development of detailed family pedigree chart
- Discussion of testing implications with healthcare provider
- Understanding of potential results and their meanings
Take Control of Your Reproductive Health Today
Don’t let uncertainty about reproductive health concerns affect your quality of life. Our AKR1C4 genetic test provides the clarity and answers you need for informed medical decisions. Contact our genetic specialists today to schedule your test and begin your journey toward understanding and managing your reproductive health.
Call or WhatsApp us now at +1(267) 388-9828 to book your AKR1C4 Genetic DNA Test and take the first step toward comprehensive reproductive health management.
